Sze Wa Chan, Brian Tomlinson, Paul Chan, & Christopher Wai Kei Lam. (2021). The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSze Wa Chan, Brian Tomlinson, Paul Chan, and Christopher Wai Kei Lam. The Beneficial Effects of Ganoderma Lucidum on Cardiovascular and Metabolic Disease Risk. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationSze Wa Chan, et al. The Beneficial Effects of Ganoderma Lucidum on Cardiovascular and Metabolic Disease Risk. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.